SLC5A2 and kidney failure: Prescription of some medication classes that decrease risk of kidney failure is recommended for individuals with UACR > 30 mg/g, including renin-angiotensin system blockers, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and nonsteroidal mineralocorticoid antagonists in patients with diabetes [6–10].